WS #13409
Holding: newest synthesis is 98d 12h old
Novo Nordisk hikes outlook but shares fall 5% as guidance disappoints; Q2 sales up 3% cc.
Novo Nordisk guidance disappoints
Novo Nordisk hikes outlook but shares fall 5% as guidance disappoints; Q2 sales up 3% cc.